Pharmaceutical Executive
In this demanding environment, yesterday’s product launch playbook can no longer be relied upon to yield the expected patient or business outcomes, writes Boris Bogdan.
Boris Bogdan, M.D
Advertisement
Articles by Boris Bogdan, M.D
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
Beyond the Molecule: The New Competitive Battlefield in Oncology
2
FDA Approves Beqalzi for Relapsed or Refractory Mantle Cell Lymphoma, Inqovi in Combination with Venetoclax
3
Pharmaceutical Executive Daily: FDA Approves Beqalzi and Inqovi
4
Eli Lilly’s Foundayo and Lower-Dose Zepbound Helped Maintain Weight Loss in Patients Switching from Injectables
5